Dragonfly Therapeutics, Inc. | LinkedIn (original) (raw)

About us

Dragonfly Therapeutics is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing therapies that use its novel multispecific antibody technology to harness the body's immune system to bring breakthrough treatments to patients. In addition to its wholly owned clinical assets, Dragonfly has a deep pipeline of wholly owned preclinical candidates discovered using its proprietary platform, as well as productive collaborations with Merck, AbbVie, Gilead and Bristol Myers Squibb in a broad range of disease areas. For more information, email info@dragonflytx.com.

Industry

Biotechnology Research

Company size

51-200 employees

Headquarters

Waltham, MA

Type

Privately Held

Founded

2016

Specialties

immuno-oncology

Locations

Employees at Dragonfly Therapeutics, Inc.

Updates

13,187 followers
1w Edited
If you missed the first poster session, you can still make it to this evening's! One of our poster abstracts was selected for the top 100 #SITC24!
We're super proud to be in the top 3 Best Biotech Startup Employers in the Boston area by @Forbes for 2024! 3000 privately-held Startup companies were evaluated on 3 primary criteria: company reputation, employee satisfaction and growth (each Startup must also have been started from scratch, founded between 2014 and 2021, headquartered in the U.S., and have more than 50 employees). https://lnkd.in/gic_9qPz
Meet America’s Best Startup Employers 2024 forbes.com
We moved! So wonderful to all be together under one roof, in a beautiful new facility. Ribbon Cutting Ceremony & Celebration today, with CEO Bill Haney holding the big scissors and doing the honors.

Join now to see what you are missing

Join now